GlassScriptPhysician profile
Shawn K Core
NPI 1801831250
$3,688.41
in general payments reported to CMS, 2019-2025
16 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $372 · 2022: $49.99 · 2023: $1,909 · 2024: $1,065 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,466 · Travel and Lodging: $787 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,466.08 |
| Travel and Lodging | $786.73 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $965.53 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $813.55 | 2023 | Iovera |
| Novo Nordisk INC | $664.95 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $296.31 | 2023-2025 | Evenity, Prolia, Tezspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $212.49 | 2023-2025 | Caplyta |
| Alkermes, INC. | $161.11 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $127.05 | 2024-2025 | Airsupra |
| Inspire Medical Systems, INC. | $108.52 | 2023 | Inspire |
| Harmony Biosciences LLC | $66.53 | 2024 | |
| Exact Sciences Corporation | $60.48 | 2023-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $60.38 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.99 | 2022 | |
| Gilead Sciences, INC. | $38.41 | 2021-2023 | |
| Exeltis, USA INC. | $29.08 | 2023-2024 | Slynd |
| Abbott Laboratories | $18.61 | 2025 | Freestyle Libre 3 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.42 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Core listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.